Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Aursnes, I' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 15 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Nordeng, H; Eskild, A; Nesheim, BI; Aursnes, I; Jacobsen, G
      Drug use during early pregnancy - The impact of maternal illness, outcome of prior pregnancies and socio-demographic factors

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    2. Landmark, K; Aursnes, I
      Infarct size as assessed by peak enzyme levels is reduced in patients who are using angiotensin-converting enzyme inhibitors at the onset of infarction

      CLINICAL DRUG INVESTIGATION
    3. Aursnes, I; Storvik, G; Gasemyr, J; Natvig, B
      A Bayesian analysis of bisphosphonate effects and cost-effectiveness in post-menopausal osteoporosis

      PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
    4. Aursnes, I; Landmark, K
      More non-Q-wave myocardial infarctions but similar infarct sizes in patients with hypertension

      BLOOD PRESSURE
    5. Aursnes, I
      Drugs affecting lipid metabolism

      SIDE EFFECTS OF DRUGS ANNUAL 23
    6. Reikvam, A; Aursnes, I
      Hospital mortality from acute myocardial infarction has been modestly reduced after introduction of thrombolytics and aspirin: Results from a new analytical approach

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    7. LANDMARK K; REIKVAM A; ABDELNOOR M; SIVERTSSEN E; AURSNES I
      ACUTE MYOCARDIAL-INFARCTION MORTALITY RELATED TO USE OF CALCIUM-ANTAGONISTS BEFORE ADMISSION TO HOSPITAL

      Cardiovascular drugs and therapy
    8. Aursnes, I
      Drugs affecting lipid metabolism

      SIDE EFFECTS OF DRUGS ANNUAL 21
    9. NGUYEN KN; AURSNES I; KJEKSHUS J
      INTERACTION BETWEEN ENALAPRIL AND ASPIRIN ON MORTALITY AFTER ACUTE MYOCARDIAL-INFARCTION - SUBGROUP ANALYSIS OF THE COOPERATIVE NEW SCANDINAVIAN ENALAPRIL SURVIVAL STUDY-II (CONSENSUS-II)

      The American journal of cardiology
    10. THORVIK E; AURSNES I; KRISTIANSEN IS; WAALER HT
      COST-EFFECTIVENESS OF CHOLESTEROL-LOWERING DRUGS - A REVIEW OF THE EVIDENCE

      Wiener Klinische Wochenschrift
    11. AURSNES I; MIDTBO K
      CORRELATIONS OF EXERCISE TEST AND QUALITY-OF-LIFE VARIABLES WITH CLINICAL IMPROVEMENT IN EFFORT ANGINA

      Pharmacotherapy
    12. MUNDAL HH; MELTZER HM; AURSNES I
      BLEEDING TIMES RELATED TO SERUM TRIGLYCERIDE LEVELS IN HEALTHY-YOUNG ADULTS

      Thrombosis research
    13. AURSNES I; THORVIK E; FORSEN L; KRISTIANSEN IS; WAALER HT
      EVALUATION OF THE COST-EFFECTIVENESS RATIO OF CHOLESTEROL-LOWERING DRUGS IN SECONDARY PREVENTION OF MYOCARDIAL-INFARCTION

      Circulation
    14. AURSNES I; THORVIK E; FORSEN L; KRISTIANSEN IS; WAALER HT
      EVALUATION OF THE COST-EFFECTIVENESS RATIO OF CHOLESTEROL-LOWERING DRUGS IN SECONDARY PREVENTION OF MYOCARDIAL-INFARCTION

      Circulation
    15. AURSNES I; MUNDAL HH; MELTZER HM
      CAN LOWERING OF SERUM TRIGLYCERIDE LEVELS PROLONG BLEEDING TIMES

      Thrombosis and haemostasis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 12:48:22